! The Capitol Complex is closed to the public due to COVID-19. All meetings will be held virtually online. View virtual meeting instructions (PDF).

Download Zipped Introduced WordPerfect SB0270.ZIP
[Status][Bill Documents][Fiscal Note][Bills Directory]

S.B. 270

             1     

CONTROLLED SUBSTANCE AMENDMENTS

             2     
2013 GENERAL SESSION

             3     
STATE OF UTAH

             4     
Chief Sponsor: Evan J. Vickers

             5     
House Sponsor: Paul Ray

             6     
             7      LONG TITLE
             8      General Description:
             9          This bill amends provisions of the Utah Controlled Substances Act regarding Schedule
             10      V controlled substances and unscheduled controlled substances.
             11      Highlighted Provisions:
             12          This bill:
             13          .    adds all forms of tramadol to the list of Schedule V controlled substances; and
             14          .    adds new "spice" and "bath salts" analogs to the list of unscheduled controlled
             15      substances.
             16      Money Appropriated in this Bill:
             17          None
             18      Other Special Clauses:
             19          None
             20      Utah Code Sections Affected:
             21      AMENDS:
             22          58-37-4, as last amended by Laws of Utah 2012, Chapter 297
             23          58-37-4.2, as last amended by Laws of Utah 2012, Chapter 297
             24     
             25      Be it enacted by the Legislature of the state of Utah:
             26          Section 1. Section 58-37-4 is amended to read:
             27           58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings


             28      required -- Specific substances included in schedules.
             29          (1) There are established five schedules of controlled substances known as Schedules I,
             30      II, III, IV, and V which consist of substances listed in this section.
             31          (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by
             32      the official name, common or usual name, chemical name, or brand name designated:
             33          (a) Schedule I:
             34          (i) Unless specifically excepted or unless listed in another schedule, any of the
             35      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             36      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             37      chemical designation:
             38          (A) Acetyl-alpha-methylfentanyl(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-
             39      N-phenylacetamide);
             40          (B) Acetylmethadol;
             41          (C) Allylprodine;
             42          (D) Alphacetylmethadol, except levo-alphacetylmethadol also known as
             43      levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
             44          (E) Alphameprodine;
             45          (F) Alphamethadol;
             46          (G) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
             47      propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
             48          (H) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
             49      piperidinyl]-N-phenylpropanamide);
             50          (I) Benzylpiperazine;
             51          (J) Benzethidine;
             52          (K) Betacetylmethadol;
             53          (L) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
             54      piperidinyl]-N-phenylpropanamide);
             55          (M) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
             56      phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
             57          (N) Betameprodine;
             58          (O) Betamethadol;


             59          (P) Betaprodine;
             60          (Q) Clonitazene;
             61          (R) Dextromoramide;
             62          (S) Diampromide;
             63          (T) Diethylthiambutene;
             64          (U) Difenoxin;
             65          (V) Dimenoxadol;
             66          (W) Dimepheptanol;
             67          (X) Dimethylthiambutene;
             68          (Y) Dioxaphetyl butyrate;
             69          (Z) Dipipanone;
             70          (AA) Ethylmethylthiambutene;
             71          (BB) Etonitazene;
             72          (CC) Etoxeridine;
             73          (DD) Furethidine;
             74          (EE) Hydroxypethidine;
             75          (FF) Ketobemidone;
             76          (GG) Levomoramide;
             77          (HH) Levophenacylmorphan;
             78          (II) Morpheridine;
             79          (JJ) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
             80          (KK) Noracymethadol;
             81          (LL) Norlevorphanol;
             82          (MM) Normethadone;
             83          (NN) Norpipanone;
             84          (OO) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
             85      propanamide;
             86          (PP) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
             87          (QQ) Phenadoxone;
             88          (RR) Phenampromide;
             89          (SS) Phenomorphan;


             90          (TT) Phenoperidine;
             91          (UU) Piritramide;
             92          (VV) Proheptazine;
             93          (WW) Properidine;
             94          (XX) Propiram;
             95          (YY) Racemoramide;
             96          (ZZ) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
             97          (AAA) Tilidine;
             98          (BBB) Trimeperidine;
             99          (CCC) 3-methylfentanyl, including the optical and geometric isomers
             100      (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
             101          (DDD) 3-methylthiofentanyl
             102      (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
             103          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             104      following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
             105      salts, isomers, and salts of isomers is possible within the specific chemical designation:
             106          (A) Acetorphine;
             107          (B) Acetyldihydrocodeine;
             108          (C) Benzylmorphine;
             109          (D) Codeine methylbromide;
             110          (E) Codeine-N-Oxide;
             111          (F) Cyprenorphine;
             112          (G) Desomorphine;
             113          (H) Dihydromorphine;
             114          (I) Drotebanol;
             115          (J) Etorphine (except hydrochloride salt);
             116          (K) Heroin;
             117          (L) Hydromorphinol;
             118          (M) Methyldesorphine;
             119          (N) Methylhydromorphine;
             120          (O) Morphine methylbromide;


             121          (P) Morphine methylsulfonate;
             122          (Q) Morphine-N-Oxide;
             123          (R) Myrophine;
             124          (S) Nicocodeine;
             125          (T) Nicomorphine;
             126          (U) Normorphine;
             127          (V) Pholcodine; and
             128          (W) Thebacon.
             129          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             130      compound, mixture, or preparation which contains any quantity of the following hallucinogenic
             131      substances, or which contains any of their salts, isomers, and salts of isomers when the
             132      existence of the salts, isomers, and salts of isomers is possible within the specific chemical
             133      designation; as used in this Subsection (2)(iii) only, "isomer" includes the optical, position, and
             134      geometric isomers:
             135          (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
             136      .-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
             137          (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
             138      4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
             139          (C) 4-bromo-2,5-dimethoxypenethylamine, some trade or other names:
             140      2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
             141          (D) 2,5-dimethoxyamphetamine, some trade or other names:
             142      2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
             143          (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
             144          (F) 4-methoxyamphetamine, some trade or other names:
             145      4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;
             146          (G) 5-methoxy-3,4-methylenedioxyamphetamine;
             147          (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
             148      4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";
             149          (I) 3,4-methylenedioxy amphetamine;
             150          (J) 3,4-methylenedioxymethamphetamine (MDMA);
             151          (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-


             152      alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
             153          (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
             154      N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
             155          (M) 3,4,5-trimethoxy amphetamine;
             156          (N) Bufotenine, some trade and other names:
             157      3-(.-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
             158      N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
             159          (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
             160          (P) Dimethyltryptamine, some trade or other names: DMT;
             161          (Q) Ibogaine, some trade and other names:
             162      7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
             163      [5,4-b] indole; Tabernanthe iboga;
             164          (R) Lysergic acid diethylamide;
             165          (S) Marijuana;
             166          (T) Mescaline;
             167          (U) Parahexyl, some trade or other names:
             168      3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
             169          (V) Peyote, meaning all parts of the plant presently classified botanically as
             170      Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
             171      any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
             172      preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
             173          (W) N-ethyl-3-piperidyl benzilate;
             174          (X) N-methyl-3-piperidyl benzilate;
             175          (Y) Psilocybin;
             176          (Z) Psilocyn;
             177          (AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
             178      (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis
             179      plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
             180      and their isomers with similar chemical structure and pharmacological activity to those
             181      substances contained in the plant, such as the following: .1 cis or trans tetrahydrocannabinol,
             182      and their optical isomers .6 cis or trans tetrahydrocannabinol, and their optical isomers .3,4


             183      cis or trans tetrahydrocannabinol, and its optical isomers, and since nomenclature of these
             184      substances is not internationally standardized, compounds of these structures, regardless of
             185      numerical designation of atomic positions covered;
             186          (BB) Ethylamine analog of phencyclidine, some trade or other names:
             187      N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
             188      N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
             189          (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
             190      1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
             191          (DD) Thiophene analog of phencyclidine, some trade or other names:
             192      1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
             193          (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
             194          (iv) Unless specifically excepted or unless listed in another schedule, any material
             195      compound, mixture, or preparation which contains any quantity of the following substances
             196      having a depressant effect on the central nervous system, including its salts, isomers, and salts
             197      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             198      specific chemical designation:
             199          (A) Mecloqualone; and
             200          (B) Methaqualone.
             201          (v) Any material, compound, mixture, or preparation containing any quantity of the
             202      following substances having a stimulant effect on the central nervous system, including their
             203      salts, isomers, and salts of isomers:
             204          (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
             205      4,5-dihydro-5-phenyl-2-oxazolamine;
             206          (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
             207      alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
             208          (C) Fenethylline;
             209          (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
             210      alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
             211      alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
             212      methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
             213      optical isomers;


             214          (E) (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
             215          (F) N-ethylamphetamine; and
             216          (G) N,N-dimethylamphetamine, also known as
             217      N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
             218          (vi) Any material, compound, mixture, or preparation which contains any quantity of
             219      the following substances, including their optical isomers, salts, and salts of isomers, subject to
             220      temporary emergency scheduling:
             221          (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
             222          (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
             223          (vii) Unless specifically excepted or unless listed in another schedule, any material,
             224      compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
             225      (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
             226          (b) Schedule II:
             227          (i) Unless specifically excepted or unless listed in another schedule, any of the
             228      following substances whether produced directly or indirectly by extraction from substances of
             229      vegetable origin, or independently by means of chemical synthesis, or by a combination of
             230      extraction and chemical synthesis:
             231          (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
             232      opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
             233      and their respective salts, but including:
             234          (I) Raw opium;
             235          (II) Opium extracts;
             236          (III) Opium fluid;
             237          (IV) Powdered opium;
             238          (V) Granulated opium;
             239          (VI) Tincture of opium;
             240          (VII) Codeine;
             241          (VIII) Ethylmorphine;
             242          (IX) Etorphine hydrochloride;
             243          (X) Hydrocodone;
             244          (XI) Hydromorphone;


             245          (XII) Metopon;
             246          (XIII) Morphine;
             247          (XIV) Oxycodone;
             248          (XV) Oxymorphone; and
             249          (XVI) Thebaine;
             250          (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
             251      identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
             252      substances may not include the isoquinoline alkaloids of opium;
             253          (C) Opium poppy and poppy straw;
             254          (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
             255      any salt, compound, derivative, or preparation which is chemically equivalent or identical with
             256      any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
             257      and salts of isomers and derivatives, whether derived from the coca plant or synthetically
             258      produced, except the substances may not include decocainized coca leaves or extraction of coca
             259      leaves, which extractions do not contain cocaine or ecgonine; and
             260          (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
             261      liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
             262          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             263      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             264      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             265      chemical designation, except dextrorphan and levopropoxyphene:
             266          (A) Alfentanil;
             267          (B) Alphaprodine;
             268          (C) Anileridine;
             269          (D) Bezitramide;
             270          (E) Bulk dextropropoxyphene (nondosage forms);
             271          (F) Carfentanil;
             272          (G) Dihydrocodeine;
             273          (H) Diphenoxylate;
             274          (I) Fentanyl;
             275          (J) Isomethadone;


             276          (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
             277      levomethadyl acetate, or LAAM;
             278          (L) Levomethorphan;
             279          (M) Levorphanol;
             280          (N) Metazocine;
             281          (O) Methadone;
             282          (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
             283          (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
             284      acid;
             285          (R) Pethidine (meperidine);
             286          (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
             287          (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
             288          (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
             289          (V) Phenazocine;
             290          (W) Piminodine;
             291          (X) Racemethorphan;
             292          (Y) Racemorphan;
             293          (Z) Remifentanil; and
             294          (AA) Sufentanil.
             295          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             296      compound, mixture, or preparation which contains any quantity of the following substances
             297      having a stimulant effect on the central nervous system:
             298          (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
             299          (B) Methamphetamine, its salts, isomers, and salts of its isomers;
             300          (C) Phenmetrazine and its salts; and
             301          (D) Methylphenidate.
             302          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             303      compound, mixture, or preparation which contains any quantity of the following substances
             304      having a depressant effect on the central nervous system, including its salts, isomers, and salts
             305      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             306      specific chemical designation:


             307          (A) Amobarbital;
             308          (B) Glutethimide;
             309          (C) Pentobarbital;
             310          (D) Phencyclidine;
             311          (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
             312      1-piperidinocyclohexanecarbonitrile (PCC); and
             313          (F) Secobarbital.
             314          (v) (A) Unless specifically excepted or unless listed in another schedule, any material,
             315      compound, mixture, or preparation which contains any quantity of Phenylacetone.
             316          (B) Some of these substances may be known by trade or other names:
             317      phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
             318          (vi) Nabilone, another name for nabilone:
             319      (.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
             320      6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
             321          (c) Schedule III:
             322          (i) Unless specifically excepted or unless listed in another schedule, any material,
             323      compound, mixture, or preparation which contains any quantity of the following substances
             324      having a stimulant effect on the central nervous system, including its salts, isomers whether
             325      optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
             326      and salts of isomers is possible within the specific chemical designation:
             327          (A) Those compounds, mixtures, or preparations in dosage unit form containing any
             328      stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
             329      listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
             330      Code of Federal Regulations, and any other drug of the quantitive composition shown in that
             331      list for those drugs or which is the same except that it contains a lesser quantity of controlled
             332      substances;
             333          (B) Benzphetamine;
             334          (C) Chlorphentermine;
             335          (D) Clortermine; and
             336          (E) Phendimetrazine.
             337          (ii) Unless specifically excepted or unless listed in another schedule, any material,


             338      compound, mixture, or preparation which contains any quantity of the following substances
             339      having a depressant effect on the central nervous system:
             340          (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
             341      pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
             342      which are not listed in any schedule;
             343          (B) Any suppository dosage form containing amobarbital, secobarbital, or
             344      pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
             345      Administration for marketing only as a suppository;
             346          (C) Any substance which contains any quantity of a derivative of barbituric acid or any
             347      salt of any of them;
             348          (D) Chlorhexadol;
             349          (E) Buprenorphine;
             350          (F) Any drug product containing gamma hydroxybutyric acid, including its salts,
             351      isomers, and salts of isomers, for which an application is approved under the federal Food,
             352      Drug, and Cosmetic Act, Section 505;
             353          (G) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
             354      . -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
             355          (H) Lysergic acid;
             356          (I) Lysergic acid amide;
             357          (J) Methyprylon;
             358          (K) Sulfondiethylmethane;
             359          (L) Sulfonethylmethane;
             360          (M) Sulfonmethane; and
             361          (N) Tiletamine and zolazepam or any of their salts, some trade or other names for a
             362      tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
             363      2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
             364      4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
             365      flupyrazapon.
             366          (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
             367      U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
             368      (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or


             369      (-)-delta-9-(trans)-tetrahydrocannabinol.
             370          (iv) Nalorphine.
             371          (v) Unless specifically excepted or unless listed in another schedule, any material,
             372      compound, mixture, or preparation containing limited quantities of any of the following
             373      narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
             374          (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             375      milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
             376      opium;
             377          (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             378      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             379      therapeutic amounts;
             380          (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             381      than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
             382      alkaloid of opium;
             383          (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             384      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             385      recognized therapeutic amounts;
             386          (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
             387      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             388      therapeutic amounts;
             389          (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
             390      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             391      recognized therapeutic amounts;
             392          (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
             393      more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             394      recognized therapeutic amounts; and
             395          (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
             396      one or more active, non-narcotic ingredients in recognized therapeutic amounts.
             397          (vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids
             398      including any of the following or any isomer, ester, salt, or derivative of the following that
             399      promotes muscle growth:


             400          (A) Boldenone;
             401          (B) Chlorotestosterone (4-chlortestosterone);
             402          (C) Clostebol;
             403          (D) Dehydrochlormethyltestosterone;
             404          (E) Dihydrotestosterone (4-dihydrotestosterone);
             405          (F) Drostanolone;
             406          (G) Ethylestrenol;
             407          (H) Fluoxymesterone;
             408          (I) Formebulone (formebolone);
             409          (J) Mesterolone;
             410          (K) Methandienone;
             411          (L) Methandranone;
             412          (M) Methandriol;
             413          (N) Methandrostenolone;
             414          (O) Methenolone;
             415          (P) Methyltestosterone;
             416          (Q) Mibolerone;
             417          (R) Nandrolone;
             418          (S) Norethandrolone;
             419          (T) Oxandrolone;
             420          (U) Oxymesterone;
             421          (V) Oxymetholone;
             422          (W) Stanolone;
             423          (X) Stanozolol;
             424          (Y) Testolactone;
             425          (Z) Testosterone; and
             426          (AA) Trenbolone.
             427          (vii) Anabolic steroids expressly intended for administration through implants to cattle
             428      or other nonhuman species, and approved by the Secretary of Health and Human Services for
             429      use, may not be classified as a controlled substance.
             430          (d) Schedule IV:


             431          (i) Unless specifically excepted or unless listed in another schedule, any material,
             432      compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
             433      less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
             434          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             435      compound, mixture, or preparation which contains any quantity of the following substances,
             436      including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
             437      salts of isomers is possible within the specific chemical designation:
             438          (A) Alprazolam;
             439          (B) Barbital;
             440          (C) Bromazepam;
             441          (D) Butorphanol;
             442          (E) Camazepam;
             443          (F) Carisoprodol;
             444          (G) Chloral betaine;
             445          (H) Chloral hydrate;
             446          (I) Chlordiazepoxide;
             447          (J) Clobazam;
             448          (K) Clonazepam;
             449          (L) Clorazepate;
             450          (M) Clotiazepam;
             451          (N) Cloxazolam;
             452          (O) Delorazepam;
             453          (P) Diazepam;
             454          (Q) Dichloralphenazone;
             455          (R) Estazolam;
             456          (S) Ethchlorvynol;
             457          (T) Ethinamate;
             458          (U) Ethyl loflazepate;
             459          (V) Fludiazepam;
             460          (W) Flunitrazepam;
             461          (X) Flurazepam;


             462          (Y) Halazepam;
             463          (Z) Haloxazolam;
             464          (AA) Ketazolam;
             465          (BB) Loprazolam;
             466          (CC) Lorazepam;
             467          (DD) Lormetazepam;
             468          (EE) Mebutamate;
             469          (FF) Medazepam;
             470          (GG) Meprobamate;
             471          (HH) Methohexital;
             472          (II) Methylphenobarbital (mephobarbital);
             473          (JJ) Midazolam;
             474          (KK) Nimetazepam;
             475          (LL) Nitrazepam;
             476          (MM) Nordiazepam;
             477          (NN) Oxazepam;
             478          (OO) Oxazolam;
             479          (PP) Paraldehyde;
             480          (QQ) Pentazocine;
             481          (RR) Petrichloral;
             482          (SS) Phenobarbital;
             483          (TT) Pinazepam;
             484          (UU) Prazepam;
             485          (VV) Quazepam;
             486          (WW) Temazepam;
             487          (XX) Tetrazepam;
             488          (YY) Triazolam;
             489          (ZZ) Zaleplon; and
             490          (AAA) Zolpidem.
             491          (iii) Any material, compound, mixture, or preparation of fenfluramine which contains
             492      any quantity of the following substances, including its salts, isomers whether optical, position,


             493      or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
             494      isomers is possible.
             495          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             496      compound, mixture, or preparation which contains any quantity of the following substances
             497      having a stimulant effect on the central nervous system, including its salts, isomers whether
             498      optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
             499      isomers, and salts of isomers is possible within the specific chemical designation:
             500          (A) Cathine ((+)-norpseudoephedrine);
             501          (B) Diethylpropion;
             502          (C) Fencamfamine;
             503          (D) Fenproprex;
             504          (E) Mazindol;
             505          (F) Mefenorex;
             506          (G) Modafinil;
             507          (H) Pemoline, including organometallic complexes and chelates thereof;
             508          (I) Phentermine;
             509          (J) Pipradrol;
             510          (K) Sibutramine; and
             511          (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
             512          (v) Unless specifically excepted or unless listed in another schedule, any material,
             513      compound, mixture, or preparation which contains any quantity of dextropropoxyphene
             514      (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
             515          (e) Schedule V: Any compound, mixture, or preparation containing any of the
             516      following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous
             517      base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in
             518      sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal
             519      qualities other than those possessed by the narcotic drug alone:
             520          (i) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
             521          (ii) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
             522      grams;
             523          (iii) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100


             524      grams;
             525          (iv) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
             526      atropine sulfate per dosage unit;
             527          (v) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
             528          (vi) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
             529      atropine sulfate per dosage unit; [and]
             530          (vii) unless specifically exempted or excluded or unless listed in another schedule, any
             531      material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
             532      effect on the central nervous system, including its salts, isomers, and salts of isomers[.]; and
             533          (viii) all forms of Tramadol.
             534          Section 2. Section 58-37-4.2 is amended to read:
             535           58-37-4.2. Listed controlled substances.
             536          The following substances, their analogs, homologs, and synthetic equivalents are listed
             537      controlled substances:
             538          (1) AM-694; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone;
             539          (2) AM-2201; 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;
             540          (3) CP 47,497 and its C6, C8, and C9 homologs; 2-[(1R,3S)-3-hydroxycyclohexyl]
             541      -5-(2-methyloctan-2-yl)phenol;
             542          (4) Ethylphenidate;
             543          [(4)] (5) Fluoromethcathinone;
             544          [(5)] (6) HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)
             545      -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
             546          [(6)] (7) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
             547      methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
             548          [(7)] (8) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;
             549          [(8)] (9) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as
             550      1-Pentyl-3-(1-naphthoyl)indole};
             551          [(9)] (10) JWH-019; 1-hexyl-3-(1-naphthoyl)indole;
             552          [(10)] (11) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as
             553      1-Butyl-3-(1-naphthoyl)indole};
             554          [(11)] (12) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;


             555          [(12)] (13) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);
             556          [(13)] (14) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;
             557          [(14)] (15) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;
             558          [(15)] (16) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;
             559          [(16)] (17) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;
             560          [(17)] (18) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;
             561          [(18)] (19) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;
             562          [(19)] (20) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;
             563          [(20)] (21) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also
             564      known as BTW-8 and SR-18};
             565          [(21)] (22) 4-methylmethcathinone {also known as mephedrone};
             566          [(22)] (23) 3,4-methylenedioxypyrovalerone {also known as MDPV};
             567          [(23)] (24) 3,4-Methylenedioxymethcathinone {also known as methylone}; [and]
             568          [(24)] (25) 4-methoxymethcathinone[.];
             569          (26) 5F-AKB48; 1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-
             570      carboxamide;
             571          (27) 25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
             572      methyl]ethanamine; and
             573          (28) 25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
             574      methyl]ethanamine.




Legislative Review Note
    as of 3-1-13 7:56 AM


Office of Legislative Research and General Counsel


[Bill Documents][Bills Directory]